DE602005016290D1 - Glichkeit - Google Patents

Glichkeit

Info

Publication number
DE602005016290D1
DE602005016290D1 DE602005016290T DE602005016290T DE602005016290D1 DE 602005016290 D1 DE602005016290 D1 DE 602005016290D1 DE 602005016290 T DE602005016290 T DE 602005016290T DE 602005016290 T DE602005016290 T DE 602005016290T DE 602005016290 D1 DE602005016290 D1 DE 602005016290D1
Authority
DE
Germany
Prior art keywords
target genes
biological sample
biological material
biological
possibility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005016290T
Other languages
English (en)
Inventor
Alexandre Pachot
Yves Pacheco
Gilles Devouassoux
Ganse Eric Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Publication of DE602005016290D1 publication Critical patent/DE602005016290D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Glass Compositions (AREA)
  • Magnetic Heads (AREA)
  • Valve Device For Special Equipments (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
DE602005016290T 2004-10-19 2005-10-17 Glichkeit Active DE602005016290D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0452366A FR2876705B1 (fr) 2004-10-19 2004-10-19 Procede pour le diagnostic d'une intolerance a l'aspirine
PCT/FR2005/050858 WO2006042995A1 (fr) 2004-10-19 2005-10-17 Procédé pour le diagnostic d'une intolérance à l'aspirine

Publications (1)

Publication Number Publication Date
DE602005016290D1 true DE602005016290D1 (de) 2009-10-08

Family

ID=34950251

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005016290T Active DE602005016290D1 (de) 2004-10-19 2005-10-17 Glichkeit

Country Status (6)

Country Link
US (1) US20080293047A1 (de)
EP (1) EP1802773B1 (de)
AT (1) ATE440968T1 (de)
DE (1) DE602005016290D1 (de)
FR (1) FR2876705B1 (de)
WO (1) WO2006042995A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP1790664A1 (de) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs
US9719842B2 (en) * 2010-07-06 2017-08-01 Norman A. Paradis Method for the discovery, validation and clinical application of multiplex biomarker algorithms based on optical, physical and/or electromagnetic patterns
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672040A (en) * 1983-05-12 1987-06-09 Advanced Magnetics, Inc. Magnetic particles for use in separations
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800159A (en) * 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US4981783A (en) * 1986-04-16 1991-01-01 Montefiore Medical Center Method for detecting pathological conditions
US5750338A (en) * 1986-10-23 1998-05-12 Amoco Corporation Target and background capture methods with amplification for affinity assays
US5700637A (en) * 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5234809A (en) * 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
CA2020958C (en) * 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US6506607B1 (en) * 1997-12-24 2003-01-14 Millennium Pharmaceuticals, Inc. Methods and compositions for the identification and assessment of prostate cancer therapies and the diagnosis of prostate cancer
US20050042630A1 (en) * 1999-01-06 2005-02-24 Chondrogene Limited Method for the detection of asthma related gene transcripts in blood
WO2003004623A2 (en) * 2001-03-27 2003-01-16 Human Genome Sciences, Inc. Human secreted proteins
FR2816958B1 (fr) * 2000-11-17 2004-11-26 Biomerieux Sa Procede d'analyse de la predisposition genetique d'un patient au diabete insulino-dependant, dispositif adapte a sa mise en oeuvre et jeu d'amorces d'amplification adapte a un tel procede
AU2002367732A1 (en) * 2001-10-31 2003-09-09 Children's Hospital Medical Center Method for diagnosis and treatment of rheumatoid arthritis
JP2004121218A (ja) * 2002-08-06 2004-04-22 Jenokkusu Soyaku Kenkyusho:Kk 気管支喘息または慢性閉塞性肺疾患の検査方法

Also Published As

Publication number Publication date
EP1802773B1 (de) 2009-08-26
ATE440968T1 (de) 2009-09-15
WO2006042995A1 (fr) 2006-04-27
FR2876705A1 (fr) 2006-04-21
FR2876705B1 (fr) 2008-12-12
EP1802773A1 (de) 2007-07-04
US20080293047A1 (en) 2008-11-27

Similar Documents

Publication Publication Date Title
Nezhad Future of portable devices for plant pathogen diagnosis
DE602006012995D1 (de) Brustkrebsdiagnoseverfahren
WO2008115185A3 (en) Use of microarrays for genomic representation selection
ATE534748T1 (de) Direkter snp-nachweis mit nichtamplifizierter dna
SG134283A1 (en) Biomarkers for liver fibrotic injury
DE602006018477D1 (de) Dna und antikörpern sowie verwendungen davon
HK1210627A1 (en) Preparing crude biological estracts using protease, suitable for preparing cdna cdna
GB0500996D0 (en) Detection method and materials therefor
ATE515488T1 (de) Click-chemie zur herstellung von reportermolekülen
DK1778867T3 (da) Fremgangsmåder og sammensætninger til detektering af nucleinsyrer i en biologisk prøve
WO2006117161A3 (en) New labelling strategies for the sensitive detection of analytes
WO2008028160A3 (en) Substrates, systems and methods for analyzing materials
WO2006116362A3 (en) Structured substrates for optical surface profiling
FR2917174B1 (fr) Analyse multiple d'echantillons sanguins
ATE491809T1 (de) Amplifikation von dna-fragmenten
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
EP1978366A4 (de) Fluoreszenzmarker für biologisches material und verfahren zur markierung von biologischem material mit fluoreszenzmarker
DE602005009693D1 (de) 2"-nitrobenzyl-modifizierte ribonukleotide
BRPI0816047A2 (pt) conjunto de oligonucleotídeos para detecção de um ácido nucleico alvo, métodos para detecção da presença ou ausência de um ácido nucleico alvo e de pelo menos dois ácidos nucleicos alvo, kit, mistura de reação e amplicon identificado por fluorescência
AR067135A1 (es) Metodos para aislar arn de fragmento largo de muestras fijas
DE602005016290D1 (de) Glichkeit
DK1390542T3 (da) Fremgangsmåde til påvisning af nukleinsyrer
Chen et al. Cellular macromolecules-tethered DNA walking indexing to explore nanoenvironments of chromatin modifications
EP1816476A4 (de) Testverfahren für nukleinsäurebindendes protein auf biochipbasis
FR2855832B1 (fr) Procede de diagnostic et/ou de pronostic d'un syndrome septique

Legal Events

Date Code Title Description
8364 No opposition during term of opposition